Marketing-authorisation holder · United States
Deproco
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FLAVALTA0.017mg base/1.7ml (eq 0.01mg base/ml); 34mg/1.7ml (20mg/ml) · Solution | Epinephrine, Lidocaine | United States | Marketed | 2026 |
| LIGNOSPAN FORTE0.02mg base/ml; 2% · Injectable | Epinephrine, Lidocaine | United States | Marketed | 2009 |
| LIGNOSPAN STANDARD0.01mg base/ml; 2% · Injectable | Epinephrine, Lidocaine | United States | Marketed | 1985 |
| SCANDONEST L0.05mg/ml; 2% · Injectable | Levonordefrin, Mepivacaine | United States | Not marketed | 1984 |
| SCANDONEST PLAIN3% · Injectable | Mepivacaine | United States | Marketed | 1984 |
| SEPTOCAINE4%; 0.0085mg base/1.7ml (4% | 4%; 0.017mg base/1.7ml (4% · Injectable | Articaine, Epinephrine | United States | Marketed | 2000 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past |
|---|